Discovery & Progress of ZN-c3, a Highly Potent & Selective WEE1 Inhibitor Undergoing Evaluation in Clinical Trials for the Treatment of Cancer

Time: 11:30 am
day: Day One

Details:

  • Discovery of ZN-c3 as a potent and selective Wee1 inhibitor
  • Exploring ZN-c3 antitumor effect as a single agent and in combination
  • Diving into recent ZN-c3 clinical data

Speakers: